The Drug Patent Two-Step
Drug companies are willing to try everything to keep their valuable patents alive.
Why Assigning Patents To Native American Tribes To Avoid Inter Partes Review Is Bad Medicine
Here are three big reasons why, according to IP columnist Tom Kulik.
Legal Is Changing. And NeoSummit Is Where The Future Is Being Built.
Legal and operational leaders are gathering May 6–7 in Fort Lauderdale to confront the questions the industry hasn't answered—with a keynote from Amanda Knox setting the tone.
The Life Sciences Law Firm Index: Patent Category Update
Which law firms were at the top of our patent category through Q3 2017?
A New Patent Loophole? Paying Off A Native American Tribe To Exploit Its Sovereign Immunity
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
The Fight To Claim A Cure
When the underlying technology is so potentially valuable, companies will go to war on multiple fronts.
Here’s An Infographic Of Drug Patents Expiring In 2017
Here's what you need to know in 2017, in an easily consumable way.
Most Law Firms’ AI Strategies Have a Big Blind Spot. Here’s How One Am Law 200 Firm is Solving It.
Most law firms, big and small, that have adopted AI are making the same mistake: they bought a tool for their lawyers and called it a strategy.